Literature DB >> 18612327

Low-molecular-weight heparins should be used with caution in patients with chronic kidney disease.

Maurizio Gallieni1, Mario Cozzolino, Chiara Ronga, Diego Brancaccio.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2008        PMID： 18612327     DOI： 10.1038/ncpneph0879

Source DB:  PubMed          Journal:  Nat Clin Pract Nephrol        ISSN： 1745-8323


× No keyword cloud information.
  3 in total

1.  Plasma anti-Xa monitoring for low-molecular-weight heparins in patients with chronic kidney disease.

Authors:  Maurizio Gallieni; Alma Martini; Antonio Granata; Maria Fusaro
Journal:  Clin Pharmacokinet       Date:  2010-11       Impact factor: 6.447

Review 2.  How to balance risks and benefits in the management of CKD patients with coronary artery disease.

Authors:  Giancarlo Marenzi; Nicola Cosentino; Carlo Guastoni
Journal:  J Nephrol       Date:  2015-02-25       Impact factor: 3.902

Review 3.  Oral anticoagulant therapy in hemodialysis patients: do the benefits outweigh the risks?

Authors:  Guido Finazzi; Giulio Mingardi
Journal:  Intern Emerg Med       Date:  2009-07-16       Impact factor: 3.397
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.